Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) EBT: 2020-2025

Historic EBT for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $24.3 million.

  • Cellebrite DI's EBT rose 111.87% to $24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.3 million, marking a year-over-year increase of 127.35%. This contributed to the annual value of -$276.0 million for FY2024, which is 265.24% down from last year.
  • According to the latest figures from Q3 2025, Cellebrite DI's EBT is $24.3 million, which was up 16.82% from $20.8 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's EBT ranged from a high of $54.5 million in Q1 2022 and a low of -$204.5 million during Q3 2024.
  • In the last 3 years, Cellebrite DI's EBT had a median value of -$12.3 million in 2023 and averaged -$26.1 million.
  • As far as peak fluctuations go, Cellebrite DI's EBT spiked by 1,141.26% in 2022, and later crashed by 3,086.38% in 2024.
  • Cellebrite DI's EBT (Quarterly) stood at $54.1 million in 2021, then tumbled by 83.18% to $9.1 million in 2022, then tumbled by 235.63% to -$12.3 million in 2023, then spiked by 261.17% to $19.9 million in 2024, then soared by 111.87% to $24.3 million in 2025.
  • Its last three reported values are $24.3 million in Q3 2025, $20.8 million for Q2 2025, and $19.3 million during Q1 2025.